肌腱蛋白C(TNC)重組蛋白
Recombinant Tenascin C (TNC)
TN-C; HXB; TN; GMEM; JI; Myotendinous antigen; Neuronectin; GP 150-225; Cytotactin; Hexabrachion; Glioma-associated-extracellular matrix antigen
- 編號RPB975Ra01
- 物種Rattus norvegicus (Rat，大鼠) 相同的名稱，不同的物種。
- 來源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細(xì)胞定位分泌, 細(xì)胞外基質(zhì)
- 預(yù)測分子量12.6kDa
- 實際分子量18kDa(差異分析請參閱說明書)
- 片段與標(biāo)簽Asp513~Ser621 with N-terminal His Tag
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液（pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300）
- 性狀凍干粉
- 純度> 90%
- 等電點5.1
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1080 ¥ 2700 ¥ 5400 ¥ 16200 ¥ 40500
- 欲了解實際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Gene sequencing
-
Figure. SDS-PAGE
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Rattus norvegicus (Rat，大鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPB975Ra06 | 肌腱蛋白C(TNC)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB975Ra01 | 肌腱蛋白C(TNC)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB975Ra03 | 肌腱蛋白C(TNC)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB975Ra02 | 肌腱蛋白C(TNC)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB975Ra05 | 肌腱蛋白C(TNC)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB975Ra02 | 肌腱蛋白C(TNC)多克隆抗體 | WB; IHC; ICC; IP. |
| PAB975Ra01 | 肌腱蛋白C(TNC)多克隆抗體 | WB,IHC |
| PAB975Ra03 | 肌腱蛋白C(TNC)多克隆抗體 | WB |
| LAB975Ra71 | 肌腱蛋白C(TNC)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| SEB975Ra | 肌腱蛋白C(TNC)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB975Ra | 肌腱蛋白C(TNC)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Medical Principles and Practice | An investigation of tenascin-C levels in rheumatic mitral stenosis and their response to percutaneous mitral balloon valvuloplasty [Pubmed: 22889719] |
| Tumor Biology | Clinical significance of serum tenascin-c levels in epithelial ovarian cancer [Springer: Source] |
| Tumor Biology | Clinical significance of serum tenascin-C levels in breast cancer [Springer: Source] |
| BioFactors | Tenascin-C is increased in atherothrombotic stroke patients and has an anti-inflammatory effect in the human carotid artery. [Pubmed:24823872] |
| Connective Tissue Research | Metabolic and cytoprotective effects of in vivo peri-patellar hyaluronic acid injections in cultured tenocytes [Pubmed:25333747] |
| K | Role of Tenascin-C in the differential diagnosis of small round blue cell tumors [Index.Php: Sdutfd] |
| Life Sci | A new predictor of mortality in hemodialysis patients; Tenascin-C [PubMed: 26390818] |
| Heart Research | Biomarkers Score for Patients with Mitral Stenosis: A useful conjunction with Wilkins’s Score for Early Intervention [Heartresearchopenjournal: Hroj5] |
| Ara?t?rmalar / Researches | Pankreas Adenokarsinomunda Serum Tenascin-C Düzeyi Potansiyel Bir Biyobelirte? Midir? [Cpdf:5C21620161255] |
| Archives of Dermatological Research | Increased tenascin C and DKK1 in vitiligo: possible role of fibroblasts in acral and non-acral disease [Pubmed:29605863] |
| Methods?in?Cell?Biology | How to detect and purify tenascin-C [Pubmed:29310788] |
| Scientific Reports | Altered transcriptional regulatory proteins in glioblastoma and YBX1 as a potential regulator of tumor invasion [Pubmed: 31358880] |
留言咨詢
